Management of CMV retinitis in HIV infected patients.

por Katlama, C
Publicado em 1997

Immune Suppression as the Etiology of Failure To Detect Anti-HBc Antibodies in Patients with Chronic Hepatitis B Virus Infection

por Avettand-Fenoel, V., Thabut, D., Katlama, C., Poynard, T., Thibault, V.
Publicado em 2006

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection.

por Autran, B, Triebel, F, Katlama, C, Rozenbaum, W, Hercend, T, Debre, P
Publicado em 1989

Relapses of CMV retinitis after 2 years of highly active antiretroviral therapy

por CASSOUX, N, BODAGHI, B, FILLET, A, CARCELAIN, G, KATLAMA, C, LEHOANG, P
Publicado em 2000

Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

por Lanoy, E, Spano, JP, Bonnet, F, Boué, F, Katlama, C, Costagliola, D
Publicado no Infect Agent Cancer (2009)

Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy

por Cassoux, N., Lumbroso, L., Bodaghi, B., Zazoun, L., Katlama, C., LeHoang, P.
Publicado em 1999

Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome.

por Lévy-Frébault, V, Pangon, B, Buré, A, Katlama, C, Marche, C, David, H L
Publicado em 1987

Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients.

por Moret, H, Guichard, M, Matheron, S, Katlama, C, Sazdovitch, V, Huraux, J M, Ingrand, D
Publicado em 1993

Epidemiology of cryptosporidiosis among European AIDS patients.

por Pedersen, C, Danner, S, Lazzarin, A, Glauser, M P, Weber, R, Katlama, C, Barton, S E, Lundgren, J D
Publicado em 1996

Early Detection of Hepatitis C Virus Infection by Use of a New Combined Antigen-Antibody Detection Assay: Potential Use for High-Risk Individuals

por Schnuriger, A., Dominguez, S., Valantin, M.-A., Tubiana, R., Duvivier, C., Ghosn, J., Simon, A., Katlama, C., Thibault, V.
Publicado em 2006

Description clinique et diagnostique sérologique des patients présentant des symptômes persistants après suspicion d’infection à SARS-COV-2

por Seang, S., Ktorza, N., Monsel, G., Abdi, B., Marcelin, A., Valantin, M., Pourcher, V., Caumes, E., Katlama, C., Tubiana, R.
Publicado no Med Mal Infect (2020)

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

por Taburet, A M, Katlama, C, Blanshard, C, Zorza, G, Gazzard, D, Dohin, E, Gazzard, B G, Frostegard, C, Singlas, E
Publicado em 1992

Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy

por Martinez, V, Caumes, E, Gambotti, L, Ittah, H, Morini, J-P, Deleuze, J, Gorin, I, Katlama, C, Bricaire, F, Dupin, N
Publicado em 2006

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study

por Schneider, L, Houssaini, A, Lambert, S, Peytavin, G, Agher, R, Chermak, A, Flandre, P, Calvez, V, Marcelin, AG, Ghosn, J, Katlama, C
Publicado em 2010

COVIDOM : une expérience de télémédecine unique pour la gestion du COVID-19

por Dinh, A., Bleibtreu, A., Deconinck, L., Katlama, C., Debuc, E., Villie, P., Leclert, J., Marchand-arvier, J., Lescure, X., Jourdain, P.
Publicado no Med Mal Infect (2020)

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

por Zylberberg, H, Benhamou, Y, Lagneaux, J, Landau, A, Chaix, M, Fontaine, H, Bochet, M, Poynard, T, Katlama, C, Pialoux, G, Brechot, C, Pol, S
Publicado em 2000

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

por Bommenel, T, Meynard, JL, Launay, O, Simon, A, Mahamat, A, Martinez, V, Gilquin, J, Katlama, C, Lascaux, AS, Pradier, C, Rouveix, E, Costagliola, D, Abgrall, S
Publicado em 2010

Upgraded Cobas Ampliprep-Cobas TaqMan Version 2.0 HIV-1 RNA Quantification Assay versus First Version: Correction of Underestimations

por Wirden, M., Tubiana, R., Fourati, S., Thevenin, M., Simon, A., Canestri, A., Ait-Arkoub, Z., Soulie, C., Marcelin, A. G., Katlama, C., Calvez, V.
Publicado em 2011

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

por Wirden, M., Tubiana, R., Marguet, F., Leroy, I., Simon, A., Bonmarchand, M., Ait-Arkoub, Z., Murphy, R., Marcelin, A. G., Katlama, C., Calvez, V.
Publicado em 2009

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

por Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait-Khaled, M, Min, S, Yeo, JM
Publicado em 2010